Table 1 Baseline patient and tumor characteristics

From: Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

 

All patients

RS < 11

RS: 11-<18

RS: 18–25

RS: 26–30

RS ≥ 31

 

N = 1801

n = 304

n = 576

n = 562

n = 171

n = 188

Gender, n (%)

 Female

1787 (99)

301 (99)

573 (99)

558 (99)

169 (99)

186 (99)

 Male

14 (<1)

3 (1)

3 (1)

4 (1)

2 (1)

2 (1)

Age

 Median (interquartile range), years

60 (52–67)

63 (56–71)

59 (51–66)

59 (53–66)

60 (54–66)

59 (50–66)

 Mean (SD), years

59.4 (10)

62.9 (10)

58.7 (10)

58.9 (9)

59.7 (10)

57.6 (12)

Age category, n (%)

 <40 years

47 (2.6)

3 (1)

7 (1)

15 (3)

4 (2)

18 (10)

 40–49 years

248 (13.8)

31 (10)

96 (17)

74 (13)

20 (12)

27 (14)

 50–59 years

580 (32.2)

67 (22)

204 (35)

199 (35)

59 (35)

51 (27)

 60–69 years

604 (33.5)

113 (37)

178 (31)

198 (35)

59 (35)

56 (30)

 70–79 years

295 (16.4)

81 (27)

80 (14)

72 (13)

27 (16)

35 (19)

 ≥80 years

27 (1.5)

9 (3)

11 (2)

4 (1)

2 (1)

1 (0)

Tumor size in the greatest dimension

 Median (interquartile range), cm

1.5 (1.1, 2.0)

1.5 (1.1–2.0)

1.5 (1.0–2.0)

1.5 (1.0–2.0)

1.5 (1.2–2.0)

1.8 (1.5–2.5)

 Mean (SD), cm

1.7 (0.8)

1.6 (0.8)

1.6 (0.8)

1.6 (0.8)

1.7 (0.8)

2.0 (0.9)

Tumor size category, n (%)

 ≤1 cm

400 (22.2)

63 (21)

143 (25)

140 (25)

32 (19)

22 (12)

 >1–2 cm

996 (55.3)

181 (60)

320 (56)

302 (54)

103 (60)

90 (48)

 >2–3 cm

313 (17.4)

48 (16)

84 (15)

94 (17)

28 (16)

59 (31)

 >3

80 (4.4)

11 (4)

24 (4)

23 (4)

7 (4)

15 (8)

 Unknown

12 (0.7)

1 (0)

5 (1)

3 (0)

1 (1)

2 (1)

Tumor grade category, n (%)

 Grade 1

258 (14.3)

61 (20)

109 (19)

73 (13)

10 (6)

5 (3)

 Grade 2

907 (50.4)

173 (57)

291 (51)

283 (51)

80 (47)

80 (43)

 Grade 3

297 (16.5)

15 (5)

56 (10)

93 (17)

48 (28)

85 (45)

 Not applicable/Unknowna

339 (18.8)

55 (18)

120 (21)

113 (20)

33 (19)

18 (10)

Tumor grade and size, n (%)

 Grade 1 and tumor size ≤1 cm

90 (4.9)

15 (5)

44 (8)

28 (5)

3 (2)

0 (0)

Histology, n (%)

 IDC

1461 (81.1)

274 (81)

451 (78)

454 (81)

139 (81)

170 (90)

 ILC

213 (11.8)

23 (8)

80 (14)

78 (14)

23 (14)

9 (5)

 Mucinous/colloid

53 (2.9)

14 (4)

20 (4)

13 (2)

5 (3)

1 (1)

 Papillary

21 (1.2)

10 (3)

6 (1)

3 (1)

0 (0)

2 (1)

 Other

53 (2.9)

10 (3)

19 (3)

14 (2)

4 (3)

6 (3)

  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, RS recurrence score
  2. a 59.8% of unknown tumor grade are ILC